Back to search

Article

Structural basis of SARS-CoV-2 polymerase inhibition by Favipiravir

2020-10-19

Abstract excerpt

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into an unprecedented global pandemic. Nucleoside analogues, such as Remdesivir and Favipiravir, can serve as the first-line broad-spectrum antiviral drugs against the newly emerging viral diseases. Recent clinical trials of these two drugs for SARS-CoV-2 treatment revealed antiviral efficacies as well as side effects with d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
54aec1ad-f1a7-59ff-a1a6-4c967b6db45f
DOI
10.1101/2020.10.19.345470
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Structural basis of SARS-CoV-2 polymerase inhibition by FavipiravirDOI 10.1101/2020.10.19.345470
Select a neighboring publication to make it the new centre.